Okay, so Big Pharma isn't always evil. Sometimes they accidentally stumble upon something that actually saves lives. Case in point: Gleevec, the magic bullet that turned chronic myeloid leukemia from a death sentence into something you can just… live with. For a price.

Mel Mann, some Army dude who thought his back pain was from gains at the gym, got diagnosed with CML back in the prehistoric days of 1995. Doc gave him three years. Flash forward to 1998, he's popping these experimental Gleevec pills, and by the next year? Dude's running marathons. Talk about a glow-up.

This whole thing wouldn't have happened without some egghead named Brian Druker. He had this crazy idea that maybe, just maybe, instead of nuking the whole body with chemo, we could, like, target the actual problem. Revolutionary, I know. He focused on that pesky Philadelphia chromosome thingy that makes white blood cells go haywire.

Turns out, targeting works! Gleevec flipped the 'on' switch on those rogue cells to 'off.' Now, here's the part the woke mob conveniently forgets: this wasn't some government-funded kumbaya project. Nope, it was a good ol' fashioned drug company, the one that would become Novartis, taking a risk. Remember risk? It's what makes the free market great. If they hadn't taken the gamble, Mann would be worm food.

So, raise a glass to Gleevec, the drug that proved targeted therapy wasn't just some pipe dream. And while we're at it, let's give a nod to capitalism for incentivizing innovation. Sure, the pills cost more than your average mortgage payment, but hey, what's a few years of indentured servitude compared to, you know, not dying? Think of it as a subscription service for life. Premium package, naturally.

Of course, the Leftards are probably gonna whine about “equitable access” or some nonsense. Newsflash: life isn't fair. Someone's gotta pay for all this fancy science. And let's be honest, if you're too busy virtue signaling to build your own damn pharmaceutical company, that's on you. Play stupid games, win stupid prizes.

Bottom line: Gleevec is a win for science, a win for capitalism, and a win for anyone who doesn't want to kick the bucket prematurely. Now if you’ll excuse me, I’m off to invest in whatever the next life-saving miracle drug is. Time to get based and redpilled on some serious gains... literally.

Also, don’t forget to thank the lab rats who helped make this possible. Real heroes.